There may be a genetic cause to chemotherapy resistance in certain patients with ovarian cancer, research showed.A certain gene may be the cause of ...

Genitourinary oncologists discuss the safety and efficacy of IO/TKI and IO/IO combination therapies in advanced renal cell carcinoma.

Over two million years of life are lost to cancer in the UK every year, according to a new study from Cancer Research UK, published today in the British ...

The phase 3 AMBASSADOR trial (also known as KEYNOTE-123) met its primary endpoint of improved disease-free survival (DFS; time from randomization to ...

A blood test may be helpful in determining which patients with advanced non-small cell lung cancer (NSCLC) undergoing immunotherapy treatment may benefit ...

While industry and political efforts may have moved the needle for some institutions regarding the chemotherapy shortage, more needs to be done, as many ...

When a local art museum posted information on social media about an upcoming exhibit, I was intrigued. The event was going to occur during breast cancer ...

Throughout her cancer journey, vaginal mucosal melanoma survivor J.B. Ward was her own best advocate, never taking no for an answer as she sought ...

I have stage 4 cancer, and I'm in remission.That sounds like a contradiction. It feels like a contradiction. When I state that phrase to strangers, there's ...

The novel drug, revumenib, led to a 23% complete remission (CR; disappearance of the disease) or complete response with a partial hematologic recovery (CRh; ...

Takeda announced that it will be working with the Food and Drug Administration (FDA) to voluntarily withdraw the tyrosine kinase inhibitor Exkivity ...

Skipping some counseling for genetic cancer testing did not increase levels of distress in participants of a trial in which a new remote model could be used ...